Search the Newsreel

EUDA|EUDA Health Holdings Ltd|Price:19.210|Chg%:-0.090

TradingKey provides a comprehensive stock analysis for EUDA Health Holdings Ltd (EUDA), highlighting its healthy fundamentals and significant growth potential. The company is currently considered fairly valued within the Healthcare Equipment & Supplies industry, despite very low institutional ownership. Analysts have issued "Buy" ratings …

EUDA Health (EUDA) registers 947,963-share resale and outlines QB token platform risks

EUDA Health Holdings Limited has filed an amended Form F-3 to register the resale of up to 947,963 ordinary shares by existing shareholders. The company, which has shifted its focus from medical services to property management and wellness distribution, reported recurring losses and material …

EUDA Health (NASDAQ: EUDA) outlines oncology cell therapy plan

EUDA Health Holdings Limited has detailed its planned collaboration under a non-binding Memorandum of Understanding with GO POSB Organoids Pte Ltd and Shenzhen Innovation Immunotechnology Co., Ltd. The initiative aims to combine GO POSB’s induced pluripotent stem cell platform and universal tumor organoid bank …

EUDA Health Holdings Ltd (EUDA) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of EUDA Health Holdings Ltd (EUDA), noting its current valuation score of 9.04 and a P/E ratio of -13.17. It highlights that EUDA ranks 42 out of 199 in the Healthcare Equipment & Supplies industry. The article also …

EUDA Health details cell therapy collaboration agreement

EUDA Health Holdings Limited (NASDAQ:EUDA) has provided further information regarding its cell therapy program, which stems from a memorandum of understanding signed on July 15, 2026. This collaboration, involving GO POSB Organoids Pte Ltd and Shenzhen Innovation Immunotechnology Co., Ltd., aims to develop cell …

EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products

EUDA Health Holdings Limited has announced a collaboration with GO POSB Organoids Pte Ltd and Shenzhen Innovation Immunotechnology Co., Ltd. to advance an integrated iPSC cell therapy program for oncology and wellness. The partnership aims to develop, manufacture, and commercialize next-generation off-the-shelf cell therapies …

EUDA Health Plans Off-the-Shelf Therapies for Oncology and Wellness

EUDA Health (NASDAQ: EUDA) has outlined an integrated cell therapy program based on a non-binding Memorandum of Understanding (MOU) signed with GO POSB Organoids and Shenzhen Innovation Immunotechnology (SIIT). The collaboration aims to develop off-the-shelf cell therapies for wellness and oncology by combining GO …

EUDA Health Holdings Ltd (EUDA) Financial Health: Profitability & Balance Sheet Analysis

EUDA Health Holdings Ltd (EUDA) has received a financial score of 4.15, placing it 199 out of 199 in the Healthcare Equipment & Supplies industry. The company's financial status is stable, but its operating efficiency is low, with a significant year-over-year decrease in revenue …

EUDA Health Holdings Ltd (EUDA) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for EUDA Health Holdings Ltd (EUDA), detailing its volatility, financial risk, and investment risk. The company has a beta value of 0.64, indicating lower volatility compared to the S&P 500. Its current risk assessment score is 1.17, placing …

EUDA Health Signs Tri-Party MOU to Develop Next-Generation Oncology Cell Therapies

EUDA Health Holdings has signed a tri-party Memorandum of Understanding (MOU) with GO POSB Organoids Pte Ltd and Shenzhen Innovation Immunotechnology Co., Ltd. to develop, manufacture, and commercialize iPSC-based, off-the-shelf oncology cell therapies. This collaboration aims to enhance EUDA's wellness portfolio and distribution in …

EUDA Health Holdings Limited (NASDAQ: EUDA) inks tri-party MOU on iPSC cell therapies

EUDA Health Holdings Limited has signed a tri-party Memorandum of Understanding with GO POSB Organoids Pte Ltd and Shenzhen Innovation Immunotechnology Co., Ltd. The collaboration aims to advance next-generation induced pluripotent stem cell (iPSC) therapies, including NK-TCR cell therapies, for cancer treatment and wellness. …

Euda Health Holdings Limited, Go Posb Organoids Pte Ltd and Shenzhen Innovation Immunotechnology Co., Ltd. Sign Tri-Party Memorandum of Understanding to Advance Next-Generation Ipsc and Nk-Tcr Cell Therapies

Euda Health Holdings Limited, Go POSB Organoids Pte Ltd, and Shenzhen Innovation Immunotechnology Co. Ltd. have signed a tri-party Memorandum of Understanding (MOU). This collaboration aims to develop, manufacture, and commercialize next-generation off-the-shelf oncology cell therapies derived from induced pluripotent stem cells (iPSC) for …

EUDA Health signs MOU for stem cell cancer therapy development

EUDA Health Holdings Limited has signed a non-binding Memorandum of Understanding (MOU) with GO POSB Organoids Pte Ltd and Shenzhen Innovation Immunotechnology Co., Ltd. This agreement aims to foster collaboration on the development, manufacturing, and commercialization of oncology cell therapies derived from induced pluripotent …

EUDA Health Holdings Signs MOU with GO POSB and SIIT for iPSC-Based Oncology Cell Therapy Collaboration

EUDA Health Holdings has signed a Memorandum of Understanding with GO POSB Organoids Pte Ltd and Shenzhen Innovation Immunotechnology

EUDA Health MOU Targets Off-the-Shelf Cancer Cell Therapies

EUDA Health (NASDAQ: EUDA) has signed a tri-party Memorandum of Understanding (MOU) with GO POSB Organoids and Shenzhen Innovation Immunotechnology (SIIT). The collaboration aims to develop, manufacture, and commercialize next-generation off-the-shelf oncology cell therapies derived from induced pluripotent stem cells (iPSC) for cancer treatment …

EUDA Health Holdings Ltd (EUDA) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of EUDA Health Holdings Ltd (EUDA)'s dividend and stock split history. It indicates that no dividends have been distributed in the past five years, but it details a significant 20-for-1 merger type stock split that occurred on March 19, …

EUDA Health Holdings Ltd Financials

This article provides a detailed financial overview of EUDA Health Holdings Ltd (EUDA), presenting key financial statements such as the income statement, balance sheet, and cash flow statement. It highlights the company's latest earnings report for FY2025, including revenue, EPS, and various financial indicators. …

EUDA Health Holdings Ltd Income Statement

This article provides the quarterly and annual income statements for EUDA Health Holdings Ltd (EUDA), offering a detailed financial overview. It presents key metrics such as total revenue, operating expenses, net income, and earnings per share across various fiscal periods. The article also includes …

EUDA|EUDA Health Holdings Ltd|Price:14.990|Chg%:+0.900

EUDA Health Holdings Ltd (EUDA) is currently trading at $14.99, up 6.57%. The company, a health technology firm operating a Southeast Asian digital healthcare ecosystem, has seen its revenue grow significantly over the past three years. Analysts have a "Buy" rating for EUDA, with …

EUDA Health Holdings Ltd (EUDA) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides an overview of EUDA Health Holdings Ltd (EUDA) shareholder structure, detailing major individual, corporate, and institutional holders and their respective proportions. It also presents a historical look at institutional shareholding data from Q4 2023 to Q1 2026, alongside recent shareholder activity …

EUDA Health Holdings Limited (NASDAQ: EUDA) Share Price, EUDA Stock News, EUDA Share Price & Updates

EUDA Health (EUDA) details 947,963-share resale and QB token platform risks

EUDA Health Holdings Limited has filed an amended F-3 form to register the resale of up to 947,963 ordinary shares, including those issued under an agreement with QB Limited, shares held by affiliates, and warrant-issuable shares. EUDA itself will not sell shares or receive …

EUDA Health Holdings Limited Regains Compliance with Nasdaq Listing Requirements

EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities

Euda Health Holdings Limited (EUDA) Stock Price | Live Quotes & Charts | NASDAQ

FAST NEWS: EUDA Health to merge with developer of cancer, women’s health treatments

What is the current Price Target and Forecast for EUDA Health Holdings Limited (EUDA)

Should I buy EUDA Health Holdings Limited (EUDA)